Brooklyn Investment Group’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,020
Closed -$214K 2035
2025
Q4
$214K Buy
+8,020
New +$175K 0.01% 1311
2025
Q3
Sell
-111
Closed -$1.39K 2773
2025
Q2
$1.39K Sell
111
-178
-62% -$2.12K ﹤0.01% 2847
2025
Q1
$3.44K Sell
289
-300
-51% -$4.09K ﹤0.01% 1960
2024
Q4
$8.62K Buy
+589
New +$8.24K ﹤0.01% 1039

Other funds holding ZYME

Brooklyn Investment Group's ZYME Position: Q1 2026 in Review

Brooklyn Investment Group sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 8,020 shares — an estimated $214K sold.

Brooklyn Investment Group first reported a position in ZYME in Q4 2024 and held it in 4 quarters. The position peaked at $214K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Brooklyn Investment Group reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Brooklyn Investment Group sold 8,020 Zymeworks shares in Q1 2026, an estimated $214K.
  • Brooklyn Investment Group first reported a position in Zymeworks in Q4 2024 and held it in 4 quarters.
  • Brooklyn Investment Group's Zymeworks position peaked at $214K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.